Logo image of SONX

SONENDO INC (SONX) Stock Fundamental Analysis

NYSE:SONX - New York Stock Exchange, Inc. - US8354311073 - Common Stock - Currency: USD

0.23  -0.01 (-4.33%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SONX. SONX was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of SONX have multiple concerns. SONX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SONX had negative earnings in the past year.
In the past year SONX has reported a negative cash flow from operations.
SONX Yearly Net Income VS EBIT VS OCF VS FCFSONX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -68.96%, SONX is doing worse than 77.83% of the companies in the same industry.
With a Return On Equity value of -161.08%, SONX is not doing good in the industry: 76.35% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -68.96%
ROE -161.08%
ROIC N/A
ROA(3y)-48.29%
ROA(5y)N/A
ROE(3y)-102.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SONX Yearly ROA, ROE, ROICSONX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -50 -100 -150

1.3 Margins

With a Gross Margin value of 26.06%, SONX is not doing good in the industry: 75.37% of the companies in the same industry are doing better.
SONX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for SONX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.24%
GM growth 5YN/A
SONX Yearly Profit, Operating, Gross MarginsSONX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

SONX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SONX has more shares outstanding
The debt/assets ratio for SONX is higher compared to a year ago.
SONX Yearly Shares OutstandingSONX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M
SONX Yearly Total Debt VS Total AssetsSONX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -7.33, we must say that SONX is in the distress zone and has some risk of bankruptcy.
SONX's Altman-Z score of -7.33 is on the low side compared to the rest of the industry. SONX is outperformed by 73.89% of its industry peers.
SONX has a Debt/Equity ratio of 0.98. This is a neutral value indicating SONX is somewhat dependend on debt financing.
SONX's Debt to Equity ratio of 0.98 is on the low side compared to the rest of the industry. SONX is outperformed by 78.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z -7.33
ROIC/WACCN/A
WACC11.71%
SONX Yearly LT Debt VS Equity VS FCFSONX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 50M -50M

2.3 Liquidity

A Current Ratio of 6.80 indicates that SONX has no problem at all paying its short term obligations.
With a decent Current ratio value of 6.80, SONX is doing good in the industry, outperforming 79.80% of the companies in the same industry.
SONX has a Quick Ratio of 5.77. This indicates that SONX is financially healthy and has no problem in meeting its short term obligations.
SONX has a better Quick ratio (5.77) than 78.33% of its industry peers.
Industry RankSector Rank
Current Ratio 6.8
Quick Ratio 5.77
SONX Yearly Current Assets VS Current LiabilitesSONX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.34% over the past year.
SONX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.92%.
Measured over the past years, SONX shows a small growth in Revenue. The Revenue has been growing by 6.25% on average per year.
EPS 1Y (TTM)72.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.21%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y6.25%
Revenue growth 5YN/A
Sales Q2Q%5.69%

3.2 Future

Based on estimates for the next years, SONX will show a very strong growth in Earnings Per Share. The EPS will grow by 21.40% on average per year.
Based on estimates for the next years, SONX will show a quite strong growth in Revenue. The Revenue will grow by 18.20% on average per year.
EPS Next Y65.53%
EPS Next 2Y30.85%
EPS Next 3Y21.4%
EPS Next 5YN/A
Revenue Next Year8.44%
Revenue Next 2Y14.38%
Revenue Next 3Y18.2%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SONX Yearly Revenue VS EstimatesSONX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SONX Yearly EPS VS EstimatesSONX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SONX. In the last year negative earnings were reported.
Also next year SONX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SONX Price Earnings VS Forward Price EarningsSONX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SONX Per share dataSONX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

SONX's earnings are expected to grow with 21.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.85%
EPS Next 3Y21.4%

More info and screens

0

5. Dividend

5.1 Amount

SONX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONENDO INC

NYSE:SONX (11/21/2023, 8:04:01 PM)

0.23

-0.01 (-4.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-08 2023-11-08/amc
Earnings (Next)03-09 2024-03-09/amc
Inst Owners11.63%
Inst Owner Change0%
Ins Owners24.26%
Ins Owner Change26.58%
Market Cap12.48M
Analysts80
Price Target1.75 (660.87%)
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.05%
Min EPS beat(2)-26.29%
Max EPS beat(2)0.18%
EPS beat(4)2
Avg EPS beat(4)-1.71%
Min EPS beat(4)-26.29%
Max EPS beat(4)23.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-3.82%
Max Revenue beat(2)-1.48%
Revenue beat(4)2
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-3.82%
Max Revenue beat(4)1.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-36.28%
PT rev (3m)-37.73%
EPS NQ rev (1m)-1.82%
EPS NQ rev (3m)-1.82%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)-4.58%
Revenue NQ rev (3m)-4.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS0.82
BVpS0.7
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.96%
ROE -161.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.06%
FCFM N/A
ROA(3y)-48.29%
ROA(5y)N/A
ROE(3y)-102.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.24%
GM growth 5YN/A
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.8%
Cap/Sales 2.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.8
Quick Ratio 5.77
Altman-Z -7.33
F-Score4
WACC11.71%
ROIC/WACCN/A
Cap/Depr(3y)67.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.21%
EPS Next Y65.53%
EPS Next 2Y30.85%
EPS Next 3Y21.4%
EPS Next 5YN/A
Revenue 1Y (TTM)12.92%
Revenue growth 3Y6.25%
Revenue growth 5YN/A
Sales Q2Q%5.69%
Revenue Next Year8.44%
Revenue Next 2Y14.38%
Revenue Next 3Y18.2%
Revenue Next 5YN/A
EBIT growth 1Y-3.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.36%
EBIT Next 3Y15.86%
EBIT Next 5YN/A
FCF growth 1Y-23.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.63%
OCF growth 3YN/A
OCF growth 5YN/A